Study: Cai 2026, ERJ Open Research
Race-neutral spirometry reclassification in self-identified Black and White patients
Citation
Cai X, Canaday F, Gao S, Merrell E et al (2026). ERJ Open Research. PubMed id 42741266.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Lung function tests and race correction in spirometry Tier B moderate
B 6,107 spirometry tests in a 2010 to 2020 retrospective cohort, self-identified Black and White patients (n=6107)
Retrospective cohort comparing race-specific and GLI-Global interpretation with one-year outcomes.
Switching to the race-neutral approach reclassified 530 results (9%) for FEV1 and 595 (10%) for FVC. Black patients reclassified as abnormal had higher healthcare use and worse outcomes, including hospitalisation, than those consistently normal; White patients reclassified as normal also had worse outcomes, including higher mortality. The authors say clinical judgment is needed for results near the cut-off.
As recorded in this card: Cai X, Canaday F, Gao S, Merrell E et al (2026), ERJ Open Research, [primary]
Note: Single health system, US; the abstract text was cut off before the final limits sentence.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.